Topical Treatment of Under Eye Dark Circles and Swelling

The Connecticut Sinus Center, PC

Status and phase: Completed; Phase 2

Conditions: Edema

Treatments: Drug: Placebo; Drug: Fexofenadine

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01172522

CS910510

Details and patient eligibility

About

This study examines topical treatment of under eye circles and swelling.

Full description

This study examines topical treatment of under eyes dark circles and under eye swelling.

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Under eye dark circles and swelling

Exclusion criteria

• Under age 18
• Allergy to tested medicines

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

30 participants in 2 patient groups

Fexofenadine left; placebo right

Experimental group

Description:

Topical treatment active versus placebo. Double blind randomized placebo controlled split face intrasubject comparison.

Treatment:

Drug: Fexofenadine

Drug: Placebo

Fexofenadine right; placebo left

Experimental group

Description:

Split face double blind

Treatment:

Drug: Fexofenadine

Drug: Placebo